Search results
Results from the WOW.Com Content Network
Chlordiazepoxide, trade name Librium among others, is a sedative and hypnotic medication of the benzodiazepine class; it is used to treat anxiety, insomnia and symptoms of withdrawal from alcohol, benzodiazepines, and other drugs. Chlordiazepoxide has a medium to long half-life but its active metabolite has a very long half-life.
Active metabolites are produced when a person's body metabolizes the drug into compounds that share a similar pharmacological profile to the parent compound and thus are relevant when calculating how long the pharmacological effects of a drug will last. Long-acting benzodiazepines with long-acting active metabolites, such as diazepam and ...
Chlordiazepoxide (Librium) is the benzodiazepine of choice in uncomplicated alcohol withdrawal due to its long half-life. [12] Lorazepam or diazepam is available as an injection for patients who cannot safely take medications by mouth.
Last but certainly not least, some tricyclic antidepressants (TCAs) are used to treat anxiety disorders. ... As brand name Librium and a generic, chlordiazepoxide is typically used to treat ...
How long does COVID-19 last? Depending on whether you’ve experienced a mild or severe case of COVID-19, recovery times will vary. When it comes to mild cases of COVID-19, “in general, we would ...
This class of medication is generally effective in symptoms control, but needs to be used carefully. Although benzodiazepines have a long history of successfully treating and preventing withdrawal, there is no consensus on the ideal one to use. The most commonly used agents are long-acting benzodiazepines, such as chlordiazepoxide and diazepam ...
Here's a deeper dive into how long different types of wine will last: Red Wine A bottle of red can last between three to five days when stored in a cool, dry place with proper re-corking or using ...
A study in 2000 found that long-term benzodiazepine therapy does not result in brain abnormalities. [76] Withdrawal from high-dose use of nitrazepam anecdotally was alleged in 2001 to have caused severe shock of the whole brain with diffuse slow activity on EEG in one patient after 25 years of use. After withdrawal, abnormalities in hypofrontal ...